Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 335 followers

Latest posts

Last updated about 10 hours ago

Presentation - Adiposity: The gateway to cardiometabolic diseases (L. Fábryová)

about 12 hours ago

Presentation - Adiposity: The gateway to cardiometabolic diseases (L. Fábryová)

Presentation - Challenges and opportunities in medicines and medical devices development

about 11 hours ago

Presentation - Challenges and opportunities in medicines and medical devices development

Presentation - The safe hearts plan (Y. Azzopardi)

about 12 hours ago

Presentation - The safe hearts plan (Y. Azzopardi)

Presentation - Clinical research: opportunties and challenges (T. Lüscher)

about 12 hours ago

Presentation - Clinical research: opportunties and challenges (T. Lüscher)

Presentation - Recent (regulatory) developments in medicines for cardiovascular indications (A. Irs)

about 12 hours ago

Presentation - Recent (regulatory) developments in medicines for cardiovascular indications (A. Irs)

Presentation - Clinical imperatives for implementing regulatory science for medical devices (A. Fraser)

about 12 hours ago

Presentation - Clinical imperatives for implementing regulatory science for medical devices (A...

Presentation - Global collaboration in cardiovascular medicine development (M. Inoue)

about 12 hours ago

Presentation - Global collaboration in cardiovascular medicine development (M. Inoue)

Presentation - Cardiometabolic diseases: tackling the unmet need in cardiovascular risk reduction (J. Nabais)

about 12 hours ago

Presentation - Cardiometabolic diseases: tackling the unmet need in cardiovascular risk reduction...

Presentation - Cardiometabolic diseases: Tackling the unmet need in CV risk reduction (F. Giorgino)

about 12 hours ago

Presentation - Cardiometabolic diseases: Tackling the unmet need in CV risk reduction...

Presentation - Lived experience in unmet need (M. Holler)

about 12 hours ago

Presentation - Lived experience in unmet need (M. Holler)

Human medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation...